In this respect, the study recently published in BMC Cancer on TF, uPA and PAI in NAF samples[65] represents a shining example of how the combination of more biomolecules (alone not perfectly accurate) may significantly improve the prediction of breast atypia and/or cancer approaching near 100% accuracy, suggesting that they may be a useful breast cancer biomarker panel. This evidence concerns the gene SERPINB2 and cancer.